UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder

Blood, 2020-04, Vol.135 (16), p.1344-1352

2020

Link zum Volltext

Verfügbarkeit prüfen

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al

Haematologica (Roma), 2018-08, Vol.103 (8), p.e382

2018

Link zum Volltext

Verfügbarkeit prüfen

Liquid biopsy in non‐Hodgkin's lymphoma

Hematological oncology, 2019-06, Vol.37 (S1), p.70-74

2019

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Blood cancer discovery, 2020-09, Vol.1 (2), p.155

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin Lymphoma

Oncology (Williston Park, N.Y.), 2016-08, Vol.30 (8), p.731-744

2016

Link zum Volltext

Verfügbarkeit prüfen

Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure

Leukemia & lymphoma, 2022-02, Vol.63 (3), p.511-513

2022

Link zum Volltext

Verfügbarkeit prüfen

Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?

Journal of clinical oncology, 2022-06, Vol.40 (18), p.2063-2064

2022

Link zum Volltext

Verfügbarkeit prüfen

What is the standard of care for primary mediastinal b‐cell lymphoma; R‐CHOP or DA‐EPOCH‐R?

British journal of haematology, 2019-03, Vol.184 (5), p.836-838

2019

Link zum Volltext

Verfügbarkeit prüfen

Malignancy in STAT3 Deficient Hyper IgE Syndrome

Journal of clinical immunology, 2022-04, Vol.42 (3), p.699-702

2022

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2519-2529

2020

Link zum Volltext

Verfügbarkeit prüfen

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA

Best practice & research. Clinical haematology, 2018-09, Vol.31 (3), p.285-292

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Isavuconazole on Plasma and CSF Levels of Ibrutinib and Plasma Levels of Liposomal Doxorubicin Among Patients Receiving Teddi-R for CNS Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.8876-8877

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in the Treatment of Primary CNS Lymphoma

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S106-S109

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

Blood, 2021-11, Vol.138 (Supplement 1), p.4504-4504

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory and Untreated Mantle Cell Lymphoma: Safety, Efficacy, and Molecular Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.3537-3537

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma

The New England journal of medicine, 2017-07, Vol.377 (1), p.89-91

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis

Blood, 2018-11, Vol.132 (Supplement 1), p.785-785

2018

Link zum Volltext

Verfügbarkeit prüfen

IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S451-S451

2023

Link zum Volltext

Verfügbarkeit prüfen

POSTER: IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S210-S210

2023

Link zum Volltext

Verfügbarkeit prüfen

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Blood, 2019-11, Vol.134 (Supplement_1), p.2875-2875

2019

Link zum Volltext

Verfügbarkeit prüfen

Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR

Blood, 2019-11, Vol.134 (Supplement_1), p.4080-4080

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(96)
Bücher
(14)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al

Liquid biopsy in non‐Hodgkin's lymphoma

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin Lymphoma

Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure

Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?

What is the standard of care for primary mediastinal b‐cell lymphoma; R‐CHOP or DA‐EPOCH‐R?

Malignancy in STAT3 Deficient Hyper IgE Syndrome

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA

Effect of Isavuconazole on Plasma and CSF Levels of Ibrutinib and Plasma Levels of Liposomal Doxorubicin Among Patients Receiving Teddi-R for CNS Lymphoma

Advances in the Treatment of Primary CNS Lymphoma

Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-Cell Lymphoma: Preliminary Analysis of Safety and Efficacy

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory and Untreated Mantle Cell Lymphoma: Safety, Efficacy, and Molecular Analysis

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma

Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis

IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)

POSTER: IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed and Refractory Follicular Lymphoma: Analysis of Safety, Efficacy, and Minimal Residual Disease

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR

Suchergebnisse filtern